Sepsis Diagnostic and Prognostic Biomarker Identified
A new study identifies three sepsis subtypes and highlights ELL2 as a promising biomarker for early diagnosis and prognosis.
Tag: proteomics
All
Latest
All
Latest
Mass Spectrometry Has Potential to Enhance Sensitivity in Single-Cell Proteomics Studies
Integrating droplet-based microfluidics and mass spectrometry enhances single-cell proteomics, minimizes sample loss, increasing sensitivity.
All
Latest
Acute Myeloid Leukemia Subtypes Help Treatment
To better treat patients with acute myeloid leukemia, researchers discovered a novel subtype of the cancer via proteome and genetic analysis.
Caprion-HistoGeneX Acquires Mosaic Laboratories
Acquiring Mosaic further strengthens the North American base for Caprion-HistoGeneX’s histopathology assay development and deployment and expands the volume of pathology services.
Read More
Biodesix and Immodulon Announce Research Collaboration for Pancreatic Cancer Treatment
The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.
Read More
Interim Study Results Indicate VeriStrat Testing Influences Treatment Decisions for Non-Small Cell Lung Cancer
Patients with early-stage non-small cell lung cancer receive significantly different treatments based on the results of VeriStrat testing.
Read MoreTests Demonstrate Ability to Stratify Patients Treated with Immunotherapy
The VeriStrat test is shown to have clinical utility in predicting overall survival of afatinib-treated patients with lung cancer.
Read More